This is pretty exciting actually looking at the last presentation - i'm not sure if that was just a fancy lay out with the fork or were they implying that macro cyclization is next off the rank in spin-out / licensing opportunities ? as soon as you start to move into macro cycles you start walking into a swathe of peers Peptidream, RA Pharmaceuticals, Aileron, Ensemble Therapeutics etc etc & all the big pharma that chase this avenue through them. Also noting the recent comment of "Global repositioning of the company". Should be an interesting few weeks ahead because they will be walking all amongst those akin.
PYC Price at posting:
3.5¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)